Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Herbst, Roy S, Prof, Baas, Paul, Prof, Kim, Dong-Wan, MD, Felip, Enriqueta, MD, Pérez-Gracia, José L, MD, Han, Ji-Youn, Prof, Molina, Julian, MD, Kim, Joo-Hang, Prof, Arvis, Catherine Dubos, MD, Ahn, Myung-Ju, Prof, Majem, Margarita, MD, Fidler, Mary J, MD, de Castro, Gilberto, MD, Garrido, Marcelo, MD, Lubiniecki, Gregory M, MD, Shentu, Yue, PhD, Im, Ellie, MD, Dolled-Filhart, Marisa, PhD, Garon, Edward B, MD
Published in The Lancet (British edition) (09.04.2016)
Published in The Lancet (British edition) (09.04.2016)
Get full text
Journal Article
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study
Sequist, Lecia V, Han, Ji-Youn, Ahn, Myung-Ju, Cho, Byoung Chul, Yu, Helena, Kim, Sang-We, Yang, James Chih-Hsin, Lee, Jong Seok, Su, Wu-Chou, Kowalski, Dariusz, Orlov, Sergey, Cantarini, Mireille, Verheijen, Remy B, Mellemgaard, Anders, Ottesen, Lone, Frewer, Paul, Ou, Xiaoling, Oxnard, Geoffrey
Published in The lancet oncology (01.03.2020)
Published in The lancet oncology (01.03.2020)
Get full text
Journal Article
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
Goss, Glenwood, Dr Prof, Tsai, Chun-Ming, Prof, Shepherd, Frances A, Prof, Bazhenova, Lyudmila, Prof, Lee, Jong Seok, MD, Chang, Gee-Chen, MD, Crino, Lucio, MD, Satouchi, Miyako, MD, Chu, Quincy, MD, Hida, Toyoaki, MD, Han, Ji-Youn, Prof, Juan, Oscar, MD, Dunphy, Frank, Prof, Nishio, Makoto, MD, Kang, Jin-Hyoung, MD, Majem, Margarita, MD, Mann, Helen, MSc, Cantarini, Mireille, MD, Ghiorghiu, Serban, MD, Mitsudomi, Tetsuya, Prof
Published in The lancet oncology (01.12.2016)
Published in The lancet oncology (01.12.2016)
Get full text
Journal Article
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
Wolf, Jürgen, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B, Groen, Harry J.M, Tan, Daniel S.W, Hida, Toyoaki, de Jonge, Maja, Orlov, Sergey V, Smit, Egbert F, Souquet, Pierre-Jean, Vansteenkiste, Johan, Hochmair, Maximilian, Felip, Enriqueta, Nishio, Makoto, Thomas, Michael, Ohashi, Kadoaki, Toyozawa, Ryo, Overbeck, Tobias R, de Marinis, Filippo, Kim, Tae-Min, Laack, Eckart, Robeva, Anna, Le Mouhaer, Sylvie, Waldron-Lynch, Maeve, Sankaran, Banu, Balbin, O. Alejandro, Cui, Xiaoming, Giovannini, Monica, Akimov, Mikhail, Heist, Rebecca S
Published in The New England journal of medicine (03.09.2020)
Published in The New England journal of medicine (03.09.2020)
Get full text
Journal Article
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Paik, Paul K, Felip, Enriqueta, Veillon, Remi, Sakai, Hiroshi, Cortot, Alexis B, Garassino, Marina C, Mazieres, Julien, Viteri, Santiago, Senellart, Helene, Van Meerbeeck, Jan, Raskin, Jo, Reinmuth, Niels, Conte, Pierfranco, Kowalski, Dariusz, Cho, Byoung Chul, Patel, Jyoti D, Horn, Leora, Griesinger, Frank, Han, Ji-Youn, Kim, Young-Chul, Chang, Gee-Chen, Tsai, Chen-Liang, Yang, James C.-H, Chen, Yuh-Min, Smit, Egbert F, van der Wekken, Anthonie J, Kato, Terufumi, Juraeva, Dilafruz, Stroh, Christopher, Bruns, Rolf, Straub, Josef, Johne, Andreas, Scheele, Jürgen, Heymach, John V, Le, Xiuning
Published in The New England journal of medicine (03.09.2020)
Published in The New England journal of medicine (03.09.2020)
Get full text
Journal Article
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Camidge, D Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C H, Han, Ji-Youn, Hochmair, Maximilian J, Lee, Ki Hyeong, Delmonte, Angelo, García Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander, Gettinger, Scott N, Tiseo, Marcello, Lin, Huamao M, Gupta, Neeraj, Hanley, Michael J, Ni, Quanhong, Zhang, Pingkuan, Popat, Sanjay
Published in Journal of clinical oncology (01.11.2020)
Published in Journal of clinical oncology (01.11.2020)
Get full text
Journal Article
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer
Papadimitrakopoulou, Vassiliki A., Han, Ji‐Youn, Ahn, Myung‐Ju, Ramalingam, Suresh S., Delmonte, Angelo, Hsia, Te‐Chun, Laskin, Janessa, Kim, Sang‐We, He, Yong, Tsai, Chun‐Ming, Hida, Toyoaki, Maemondo, Makoto, Kato, Terufumi, Jenkins, Suzanne, Patel, Sabina, Huang, Xiangning, Laus, Gianluca, Markovets, Aleksandra, Thress, Kenneth S., Wu, Yi‐Long, Mok, Tony
Published in Cancer (15.01.2020)
Published in Cancer (15.01.2020)
Get full text
Journal Article
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Camidge, D. Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C.H., Han, Ji-Youn, Hochmair, Maximilian J., Lee, Ki Hyeong, Delmonte, Angelo, Garcia Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander I., Gettinger, Scott N., Tiseo, Marcello, Lin, Huamao M., Liu, Yuyin, Vranceanu, Florin, Niu, Huifeng, Zhang, Pingkuan, Popat, Sanjay
Published in Journal of thoracic oncology (01.12.2021)
Published in Journal of thoracic oncology (01.12.2021)
Get full text
Journal Article
A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non–small cell lung cancer with EGFR mutation
Lee, Youngjoo, Kim, Hye Ryun, Hong, Min Hee, Lee, Ki Hyeong, Park, Keon Uk, Lee, Geon Kook, Kim, Hyae Young, Lee, Soo‐Hyun, Lim, Kun Young, Yoon, Sung Jin, Cho, Byoung Chul, Han, Ji‐Youn
Published in Cancer (01.02.2023)
Published in Cancer (01.02.2023)
Get full text
Journal Article
First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
Han, Ji-Youn, Park, Keunchil, Kim, Sang-We, Lee, Dae Ho, Kim, Hyae Young, Kim, Heung Tae, Ahn, Myung Ju, Yun, Tak, Ahn, Jin Seok, Suh, Cheolwon, Lee, Jung-Shin, Yoon, Sung Jin, Han, Jong Hee, Lee, Jae Won, Jo, Sook Jung, Lee, Jin Soo
Published in Journal of clinical oncology (01.04.2012)
Published in Journal of clinical oncology (01.04.2012)
Get full text
Journal Article
Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial
Chmielecki, Juliann, Mok, Tony, Wu, Yi-Long, Han, Ji-Youn, Ahn, Myung-Ju, Ramalingam, Suresh S., John, Thomas, Okamoto, Isamu, Yang, James Chih-Hsin, Shepherd, Frances A., Bulusu, Krishna C., Laus, Gianluca, Collins, Barbara, Barrett, J. Carl, Hartmaier, Ryan J., Papadimitrakopoulou, Vassiliki
Published in Nature communications (27.02.2023)
Published in Nature communications (27.02.2023)
Get full text
Journal Article
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
Ahn, Myung-Ju, Han, Ji-Youn, Lee, Ki Hyeong, Kim, Sang-We, Kim, Dong-Wan, Lee, Yun-Gyoo, Cho, Eun Kyung, Kim, Joo-Hang, Lee, Gyeong-Won, Lee, Jong-Seok, Min, Young Joo, Kim, Jin-Soo, Lee, Sung Sook, Kim, Hye Ryun, Hong, Min Hee, Ahn, Jin Seok, Sun, Jong-Mu, Kim, Heung Tae, Lee, Dae Ho, Kim, Sohee, Cho, Byoung Chul
Published in The lancet oncology (01.12.2019)
Published in The lancet oncology (01.12.2019)
Get full text
Journal Article
Comparison between MGI and Illumina sequencing platforms for whole genome sequencing
Jeon, Sol A., Park, Jong Lyul, Park, Seung-Jin, Kim, Jeong Hwan, Goh, Sung-Ho, Han, Ji-Youn, Kim, Seon-Young
Published in Genes & genomics (01.07.2021)
Published in Genes & genomics (01.07.2021)
Get full text
Journal Article
Olmutinib in T790M‐positive non–small cell lung cancer after failure of first‐line epidermal growth factor receptor‐tyrosine kinase inhibitor therapy: A global, phase 2 study
Park, Keunchil, Jӓnne, Pasi A., Kim, Dong‐Wan, Han, Ji‐Youn, Wu, Ming‐Fang, Lee, Jong‐Seok, Kang, Jin‐Hyoung, Lee, Dae Ho, Cho, Byoung Chul, Yu, Chong‐Jen, Pang, Yong Kek, Felip, Enriqueta, Kim, Hyunjin, Baek, Eunhye, Noh, Young Su
Published in Cancer (01.05.2021)
Published in Cancer (01.05.2021)
Get full text
Journal Article
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
Gandara, David R., von Pawel, Joachim, Mazieres, Julien, Sullivan, Richard, Helland, Åslaug, Han, Ji-Youn, Ponce Aix, Santiago, Rittmeyer, Achim, Barlesi, Fabrice, Kubo, Toshio, Park, Keunchil, Goldschmidt, Jerome, Gandhi, Mayank, Yun, Cindy, Yu, Wei, Matheny, Christina, He, Pei, Sandler, Alan, Ballinger, Marcus, Fehrenbacher, Louis
Published in Journal of thoracic oncology (01.12.2018)
Published in Journal of thoracic oncology (01.12.2018)
Get full text
Journal Article
Seasonal influences on the efficacy of anti–programmed cell death (ligand) 1 inhibitors in lung cancer
Cho, Hyunsoon, Kwon, Hoejun, Kim, Se Hyun, Ahn, Hyung‐Min, Choi, Beom K., Lee, Geon Kook, Park, Seog‐Yun, Lim, Hyun‐ju, Hwang, Jung‐Ah, Lim, Jiyeon, Han, Ji‐Youn, Lee, Youngjoo
Published in Cancer (01.11.2024)
Published in Cancer (01.11.2024)
Get full text
Journal Article
One‐Step Polymerase Chain Reaction‐Free Nanowire‐Based Plasma Cell‐Free DNA Assay to Detect EML4‐ALK Fusion and to Monitor Resistance in Lung Cancer
Lee, Youngjoo, Cho, Youngnam, Park, Eun Young, Park, Seong‐Yun, Hwang, Kum Hui, Han, Ji‐Youn
Published in The oncologist (Dayton, Ohio) (01.10.2021)
Published in The oncologist (Dayton, Ohio) (01.10.2021)
Get full text
Journal Article
Cancer Patients’ Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in Korea
Chun, June Young, Kim, Se Ik, Park, Eun Young, Park, Sang-Yoon, Koh, Su-Jin, Cha, Yongjun, Yoo, Heon Jong, Joung, Jae Young, Yoon, Hong Man, Eom, Bang Wool, Park, Chul Min, Han, Ji-Youn, Kim, Miso, Lee, Dae-Won, Kim, Jae-Weon, Keam, Bhumsuk, Lee, Maria, Kim, Tae Min, Choi, Young Ju, Chang, Yoon Jung, Lim, Myong Cheol
Published in Cancers (01.08.2021)
Published in Cancers (01.08.2021)
Get full text
Journal Article
Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1
Shin, Dong Hoon, Kim, Sun Ha, Choi, Minyoung, Bae, Young-Ki, Han, Chungyong, Choi, Beom K., Kim, Sang Soo, Han, Ji-Youn
Published in Oncogene (05.01.2022)
Published in Oncogene (05.01.2022)
Get full text
Journal Article